Studies have found that FGF21 levels can be used as a biomarker related to the prognosis of patients with diabetic nephropathy (El-Saeed and El-Mohasseb, 2017; Chang et al., 2021). The gene discussed is FGF21; the disease is diabetic kidney disease.